97255 ⎘
Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
ANTIBODY THAT BINDS SPECIFICALLY TO THE SARS COV 2 SPIKE PROTEIN, AND METHODS FOR ITS MANUFACTURE
#2BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN A
#3IMMUNE MOTIFS IN PRODUCTS FROM DOMESTIC ANIMALS
#4Antibody purification
#5Stable pooled breastmilk antibodies for oral delivery
#6COMBINATION OF ANTI-CD303 AND ANTI-HER2 ANTIBODIES
#7HIGHLY GALACTOSYLATED ANTI-TNF-ALPHA ANTIBODIES AND USES THEREOF
#8HIGHLY GALACTOSYLATED ANTI-TNF-ALPHA ANTIBODIES AND USES THEREOF
#9Immunoglobulin polypeptide fractions from products of domestic animals
#10RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES
#11Therapeutic composition of camel milk
#12RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES
#13METHOD FOR THE PURIFICATION OF A THERAPEUTIC RECOMBINANT PROTEIN FROM TRANSGENIC MILK
#14ANTIBODY THERAPY FOR MODULATING FUNCTION OF INTESTINAL RECEPTORS AND METHODS OF TREATING DIABETES AND OBESITY
#15Modified colostrum protein and application thereof
#16PRODUCTION OF FC FRAGMENTS
#17ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODIES
#18Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#19Recombinant production of mixtures of antibodies
#20Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis
#21Methods and compositions for the treatment and/or prophylaxis of associated disease
#22Highly galactosylated anti-TNF-α antibodies and uses thereof
#23ANTIBODY THERAPY FOR MODULATING FUNCTION OF INTESTINAL RECEPTORS AND METHODS OF TREATING DIABETES AND OBESITY
#24Compositions comprising TNF-specific antibodies for oral delivery and methods of use thereof to treat inflammatory bowel disease
#25Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
#26BOVINE POLYCLONAL ANTIBODY SPECIFIC FOR HUMAN TNF
#27Antibodies to apical intestinal receptors and methods of treating metabolic disease
#28METHODS AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSION
#29MILK DERIVED ANTIGEN SPECIFIC ANTIBODIES FOR INDUCING AN ADAPTIVE IMMUNE RESPONSE, METHODS OF PREPARATION AND USES THEREOF
#30Methods of treating mucositis using anti-TNF antibodies
#31ANTIBODY THERAPEUTICS WITH LOCAL ACTIVITY IN THE DIGESTIVE TRACT
#32POLYCLONAL ANTIBODY COMPOSITIONS
#33Method of producing an antibody using a cancer cell
#34Anti-LPS enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder
#35Antibody therapy for treatment of diseases associated with gluten intolerance
#36Therapeutic and diagnostic conjugates for use with multispecific antibodies
#37Recombinant production of mixtures of antibodies
#38IMMUNOGEN SELECTION DIRECTED IN IMMUNOGLOBULIN PACKAGES IN PLASMA AND COLOSTRUM AND METHOD OF MAKING AND USING SAME
#39PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
#40Methods of using anti-TNF antibodies for treating radiation damage to the digestive tract
#41Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
#42Targeted cryptosporidium biocides
#43Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
#44Chimeric, human and humanized anti-CSAP monoclonal antibodies
#45Production and use of novel peptide-based agents for use with bi-specific antibodies
#46MILK DERIVED ANTIGEN-SPECIFIC ANTIBODIES, METHODS OF PREPARATION AND USES THEREOF
#47TARGETED BIOCIDES
#48Production and use of novel peptide-based agents with bispecific antibodies
#49Method of prophylaxis of infection
#50Recombinant production of mixtures of antibodies
#51Production and use of novel peptide-based agents for use with bi-specific antibodies
#52Immunoglobulin fraction and process therefor
#53Transgenic bovine having reduced prion protein activity and uses thereof
#54Production and use of novel peptide-based agents for use with bi-specific antibodies
#55Chimeric, human and humanized anti-CSAp monoclonal antibodies
#56Chimeric, human and humanized anti-CSAP monoclonal antibodies
#57Chimeric, human and humanized anti-CSAp monoclonal antibodies
#58Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use
#59Method for Obtaining Modified Proteins and Viruses with Intact Native Binding Site
#60Chimeric, human and humanized anti-CSAP monoclonal antibodies
#61METHOD AND COMPOSITION FOR CONFERRING IMMUNITY IN MAMMALS
#62Antibody therapy for treatment of diseases associated with gluten intolerance
#63Targeted biocides
#64Recombinant production of mixtures of antibodies
#65Recombinant production of mixtures of antibodies
#66Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#67Production and use of novel peptide-based agents for use with bi-specific antibodies
#68Production and use of novel peptide-based agents with bispecific antibodies
#69Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
#70Recombinant production of mixtures of antibodies
#71Chimeric, human and humanized anti-CSAp monoclonal antibodies
#72Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
#73Transgenic bovines having reduced prion protein production
#74Therapeutic and diagnostic conjugates for use with multispecific antibodies